Efficacy and safety of bilastine in Japanese patients with perennial allergic rhinitis: A multicenter, randomized, double-blind, placebo-controlled, parallel-group phase III study-Reference-Cited by-同舟云学术

Efficacy and safety of bilastine in Japanese patients with perennial allergic rhinitis: A multicenter, randomized, double-blind, placebo-controlled, parallel-group phase III study

Published:2017-01 Issue:1 Volume:66 Page:97-105
ISSN:1323-8930
Container-title:Allergology International
language:en
Short-container-title:Allergology International

Author:

Okubo Kimihiro,Gotoh Minoru,Asako Mikiya,Nomura Yasuyuki,Togawa Michinori,Saito Akihiro,Honda Takayuki,Ohashi Yoshihiro

Publisher

Elsevier BV

Subject

General Medicine,Immunology and Allergy

Reference26 articles.

1. Japanese guideline for allergic rhinitis 2014;Okubo;Allergol Int,2014

2. Examination, diagnosis and classification for Japanese allergic rhinitis: Japanese guideline;Fujieda;Auris Nasus Larynx,2012

3. Prevalence of allergic rhinitis and sensitization to common aeroallergens in a Japanese population;Sakashita;Int Arch Allergy Immunol,2010

4. Consensus statement on the treatment of allergic rhinitis;Van Cauwenberge;Allergy,2000

5. Clinical practice guideline: allergic rhinitis;Seidman;Otolaryngol Head Neck Surg,2015

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative inhibition by oral bilastine, parenteral dexchlorpheniramine, and a new bilastine parenteral (i.v. and i.m.) formulation of histamine-induced wheal and flare response: A randomised phase I trial;European Journal of Pharmaceutical Sciences;2024-12

2. Twenty-five years: The fexofenadine clinical experience;World Allergy Organization Journal;2024-09

3. Focused allergic rhinitis practice parameter for Canada;Allergy, Asthma & Clinical Immunology;2024-08-08

4. Bilastine for the treatment of allergic rhinoconjunctivitis and urticaria: results from an international Delphi study;Drugs in Context;2024-05-01

5. Aurantio-obtusin alleviates allergic responses in ovalbumin-induced rhinitis;Scientific African;2024-03